Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$150.03+1.97 (+1.33%)
Close on Nov 11, 2026Market cap $10.41BP/E 24.4Yield –
Insulet total assets
Total assets on the balance sheet at the end of each period.
Insulet's total assets was $3.42B at Sep 30, 2026. For fiscal 2025 it was $3.19B, up 3.3% from the year before. Over ten years it grew 27.8% a year on average. The highest annual figure on record is $3.19B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.19B | +3.3% |
| FY2024 | Dec 31, 2024 | $3.09B | +19.3% |
| FY2023 | Dec 31, 2023 | $2.59B | +15.0% |
| FY2022 | Dec 31, 2022 | $2.25B | +9.9% |
| FY2021 | Dec 31, 2021 | $2.05B | +9.4% |
| FY2020 | Dec 31, 2020 | $1.87B | +63.9% |
| FY2019 | Dec 31, 2019 | $1.14B | +23.1% |
| FY2018 | Dec 31, 2018 | $928.70M | +13.7% |
| FY2017 | Dec 31, 2017 | $816.74M | +78.9% |
| FY2016 | Dec 31, 2016 | $456.65M | +66.0% |
| FY2015 | Dec 31, 2015 | $275.13M | -7.4% |
| FY2014 | Dec 31, 2014 | $297.18M | +3.2% |
| FY2013 | Dec 31, 2013 | $287.96M | +45.4% |
| FY2012 | Dec 31, 2012 | $198.06M | -10.5% |
| FY2011 | Dec 31, 2011 | $221.32M | +41.7% |
| FY2010 | Dec 31, 2010 | $156.23M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.42B | +12.7% |
| Q2 FY2026 | Jun 30, 2026 | $3.17B | -8.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.99B | -15.1% |
| Q4 FY2025 | Dec 31, 2025 | $3.19B | +3.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.03B | +0.1% |
| Q2 FY2025 | Jun 30, 2025 | $3.47B | +20.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.52B | +34.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.09B | +19.3% |
| Q3 FY2024 | Sep 30, 2024 | $3.03B | +22.6% |
| Q2 FY2024 | Jun 30, 2024 | $2.88B | +20.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.62B | +14.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.59B | +15.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.47B | +13.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.39B | +12.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.29B | +10.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.25B | +9.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.17B | +8.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.11B | +9.9% |
| Q1 FY2022 | Mar 31, 2022 | $2.07B | +12.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.05B | +9.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.00B | +16.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.92B | +18.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.84B | +66.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.87B | +63.9% |
| Q3 FY2020 | Sep 30, 2020 | $1.71B | +34.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.63B | +66.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.11B | +16.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.14B | +23.1% |
| Q3 FY2019 | Sep 30, 2019 | $1.27B | +43.1% |
| Q2 FY2019 | Jun 30, 2019 | $977.72M | +16.6% |
| Q1 FY2019 | Mar 31, 2019 | $952.61M | +14.8% |
| Q4 FY2018 | Dec 31, 2018 | $928.70M | +13.7% |
| Q3 FY2018 | Sep 30, 2018 | $886.31M | +77.1% |
| Q2 FY2018 | Jun 30, 2018 | $838.86M | +82.6% |
| Q1 FY2018 | Mar 31, 2018 | $829.76M | +86.5% |
| Q4 FY2017 | Dec 31, 2017 | $816.74M | +78.9% |
| Q3 FY2017 | Sep 30, 2017 | $500.35M | – |
| Q2 FY2017 | Jun 30, 2017 | $459.33M | – |
| Q1 FY2017 | Mar 31, 2017 | $444.96M | – |
| Q4 FY2016 | Dec 31, 2016 | $456.65M | – |
See a number that looks wrong?